Overview of Dr. Powell
Dr. Simon Powell is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University College London Medical School and has been in practice 36 years. He is experienced in breast cancer, including basic, translational and clinical research. He has more than 250 publications and over 16,500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
Royal Free Hospital and University College London Medical SchoolClass of 1981
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2008 - 2026
NJ State Medical License 2020 - 2025
MA State Medical License 1993 - 2006- American Board of Radiology Radiation Oncology
Clinical Trials
- Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Start of enrollment: 2010 May 11
- Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer Start of enrollment: 2010 Sep 01
- Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer Start of enrollment: 2019 Aug 30
Publications & Presentations
PubMed
- 262 citationsDifferential Sensitivity of p53(-) and p53(+) Cells to Caffeine-induced Radiosensitization and Override of G2 DelaySimon N. Powell, Jeffrey S. DeFrank, Paul Connell, Maeve Eogan, Frederic I. Preffer
Cancer Research. 1995-04-15 - 124 citationsMetastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.Jun Li, Mercedes Duran, Ninjit Dhanota, Walid K. Chatila, Sarah E Bettigole
Cancer Discovery. 2021-05-01 - 166 citationsRAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.Benjamin H. Lok, A C Carley, Beverly G. Tchang, Simon N. Powell
Oncogene. 2013-07-25
Press Mentions
Novavax CFO Greg Covino Makes a Quick Exit as Leadership Carousel Keeps Turning; Kite Execs Fly Away to a Cell Therapy Upstart Teaming up with LyellApril 16th, 2021- Chutes & Ladders—Lilly, Bidding Adieu to Shah, Lines up Apple Exec as CDOApril 15th, 2021
- For People with Certain BRCA Mutations, Activating the Immune System Could Be Promising TreatmentDecember 1st, 2020
- Join now to see all
Grant Support
- DNA Recombinational Repair: Role Of The P53 Tumor Suppressor ProteinNational Cancer Institute2008–2010
- Roles Of BRCA1, BRCA2 In Homologous RecombinationNational Cancer Institute2008
- Radiation Oncology 2008 Gordon Research ConferenceNational Cancer Institute2008
- DNA Recombinational Repair: Role Of The P53 Tumor Suppressor ProteinNational Cancer Institute2006–2007
- Roles Of BRCA1, BRCA2 In Homologous RecombinationNational Cancer Institute2005–2007
- DNA Repair--Role Of The P53 Tumor Suppressor ProteinNational Cancer Institute2005
- Roles Of BRCA1, BRCA2 In Homologous RecombinationNational Cancer Institute2004–2005
- DNA Repair--Role Of The P53 Tumor Suppressor ProteinNational Cancer Institute2001–2005
- At: Errors In Double Strand Break RepairNational Cancer Institute2000–2003
- DNA Recombination And Radiation ResistanceNational Cancer Institute1992–1999
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
GHI PPO
Great West PPOHealth Net California Large Group PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
